18S and 25S Exonuclease Resistant Ribosomal RNA Molecules Are Produced by 5′‐End Modification During TOR Inhibition.
Yeast · 2025
DOI: 10.1002/yea.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yeast, 2025. Verfasst von Miguel A Rocha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Division, Greater Los Angeles VA Healthcare System, California, Los Angeles, USA. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, RNA, Ribosomal, Saccharomyces cerevisiae Proteins, RNA, Ribosomal, 18S. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by Elias, Genevieve, Georgianna/Atol Charitable Trust and The Monica Lester Charitable Trust..
Abstract (Originalsprache)
Saccharomyces cerevisiae yeast cells have been shown to produce 18S and 25S ribosomal RNA molecules that are resistant to degradation by exonucleases, which require a 5′ monophosphate for activity. These resistant RNA species accumulate during the diauxic shift, a phase marked by reduced TOR signaling. To further investigate the link between TOR activity and the accumulation of resistant rRNA, we examined the effects of pharmacological TOR inhibition. Treatment with rapamycin, an active TOR suppressor, led to increased levels of resistant 18S and 25S RNA. Importantly, this accumulation was also observed in cells with constitutively active RNA polymerase I (CARA), indicating that the resistant RNA species arise independently of RNA Pol I transcriptional regulation. Similarly, a TOR1‐deleted mutant of Saccharomyces cerevisiae produces resistant 18S and 25S rRNA species in a sustained manner. Thiouracil labeling revealed that rRNA molecules generated during the logarithmic growth phase can be converted into the resistant form, suggesting a posttranscriptional modification process. Furthermore, thiouracil uptake assays demonstrated that overall rRNA synthesis decreases during the diauxic phase. Notably, decapping of the resistant rRNAs restored their sensitivity to exonucleases, indicating that the resistance is conferred by 5′ end modifications, likely involving the addition of one or more phosphate groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Division, Greater Los Angeles VA Healthcare System, California, Los Angeles, USA.
- Department of Medicine, David Geffen School of Medicine at UCLA, California, Los Angeles, USA.
Förderung
- This study was funded by Elias, Genevieve, Georgianna/Atol Charitable Trust and The Monica Lester Charitable Trust.
Zitieren
APA
Rocha, M. A., Bhavani, G., & Fleischmann, J. (2025). 18S and 25S Exonuclease Resistant Ribosomal RNA Molecules Are Produced by 5′‐End Modification During TOR Inhibition. Yeast. https://doi.org/10.1002/yea.70007
Vancouver
Rocha MA, Bhavani G, Fleischmann J. 18S and 25S Exonuclease Resistant Ribosomal RNA Molecules Are Produced by 5′‐End Modification During TOR Inhibition. Yeast. 2025. doi:10.1002/yea.70007
BibTeX
@article{Rocha2025,
author = {Rocha, Miguel A and Bhavani, Gowda and Fleischmann, Jacob},
title = {18S and 25S Exonuclease Resistant Ribosomal RNA Molecules Are Produced by 5′‐End Modification During TOR Inhibition},
journal = {Yeast},
year = {2025},
doi = {10.1002/yea.70007}
}
EUVIMED